Pour le 100 anniversaire de la naissance de L. N. Tolstoj. La spécificité de la littérature et la précision de la science de la littératureFARBER, L. M.Filologiceskie Nauki Moskva. 1978, Num 3, pp 46-48Article

Local treatment of tendinopathies: a comparison between tropisetron and depot corticosteroids combined with local anestheticsSTRATZ, Th; FÄRBER, L; MÜLLER, W et al.Scandinavian journal of rheumatology. 2002, Vol 31, Num 6, pp 366-370, issn 0300-9742, 5 p.Article

Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgiaSPÄTH, M; STRATZ, T; NEECK, G et al.Scandinavian journal of rheumatology. 2004, Vol 33, Num 4, pp 267-270, issn 0300-9742, 4 p.Article

Short-term treatment of primary fibromyalgia with the 5-HT₃-Receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patientsFÄRBER, L; STRATZ, T. H; WELZEL, D et al.International journal of clinical pharmacology research. 2001, Vol 21, Num 1, pp 1-13, issn 0251-1649Article

Peripheral blood stem cell (PBSC) mobilization with chemotherapy followed by sequential IL-3 and G-CSF administration in extensively pretreated patientsKOLBE, K; PESCHEL, C; RUPILIUS, B et al.Bone marrow transplantation (Basingstoke). 1997, Vol 20, Num 12, pp 1027-1032, issn 0268-3369Article

Absorption of cyclosporine neoral early after liver transplantation : Influence of bile on oral absorptionOLDHAFER, K; HALLER, G. W; KATTNER, A et al.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2237-2238, issn 0041-1345Conference Paper

Lack of efficacy of recombinant human interleukin-6 in patients with advanced renal cell cancer : Results of a phase II studySCHULER, M; BRUNTSCH, U; SPÄTH-SCHWALBE, E et al.European journal of cancer (1990). 1998, Vol 34, Num 5, pp 754-756, issn 0959-8049Article

Comparison of efficacy, safety, and tolerability of Neoral vs Sandimmun in de novo renal transplant patients over 24 months' treatmentABENDROTH, D; BUCHHOLZ, B; LAND, W et al.Transplantation proceedings. 1997, Vol 29, Num 1-2, pp 275-276, issn 0041-1345Conference Paper

Absorption of cyclosporine neoral early after liver transplantation : Is it Possible to abandon intravenous cyclosporine A application ?HALLER, G. W; WINKLER, M; VECHSTEIN, W. O et al.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2239-2240, issn 0041-1345Conference Paper

Clinical experience in transferring kidney transplant patients from Sandimmun to Sandimmun Neoral : results after 6 monthsNEUMAYER, H.-H; FÄRBER, L; HALLER, P et al.Transplantation proceedings. 1995, Vol 27, Num 5, pp 2679-2682, issn 0041-1345Conference Paper

Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas : results of a randomized double-blind placebo-controlled study with intensified COP-BLAM ± rhCM-CSFENGELHARD, M; GERHARTZ, H; LUDWIG, W.-D et al.Annals of oncology. 1994, Vol 5, pp 123-125, issn 0923-7534, SUP2Conference Paper

Low-dose (1.25 mg/kg) cyclosporin A: Treatment of psoriasis and investigation of the influence on lipid profileMEFFERT, H; BRÄUTIGAM, M; FÄRBER, L et al.Acta dermato-venereologica. 1997, Vol 77, Num 2, pp 137-141, issn 0001-5555Article

Fibromyalgia treatment with intravenous tropisetron administrationSTRATZ, T; FÄRBER, L; VARGA, B et al.Drugs under experimental and clinical research. 2001, Vol 27, Num 3, pp 113-118, issn 0378-6501Article

Conversion to microemulsion cyclosporine in stable renal transplant patients : results after one year : Symposium on new developments in immunosuppressive drugs in the field of renal transplantationNEUMAYER, H.-H; BUDDE, K; FÄRBER, L et al.Clinical nephrology. 1996, Vol 45, Num 5, pp 326-331, issn 0301-0430Article

Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients : results after 1 yearNEUMAYER, H.-H; FÄRBER, L; HALLER, P et al.Nephrology, dialysis, transplantation (Print). 1996, Vol 11, Num 1, pp 165-172, issn 0931-0509Article

IL-2, IL-3, and IFN-gamma differently affect in vivo frequencies of circulating precursors of cytotoxic T lymphocytes (CTL-P)HLADIK, F; KOLBE, K; IRSCHICK, E. U et al.Annals of hematology (Print). 1993, Vol 67, Num 2, pp 67-74, issn 0939-5555Article

Highly purified omega-3-polyunsaturated fatty acids for topical treatment of psoriasis. Results of a double-blind, placebo-controlled multicentre studyHENNEICKE-VON ZEPELIN, H.-H; MROWIETZ, U; FÄRBER, L et al.British journal of dermatology (1951). 1993, Vol 129, Num 6, pp 713-717, issn 0007-0963Article

Etretinate or cyclosporin : a treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasisSCHOPF, R. E; HÖCHER, J; REHDER, M et al.Archives of dermatological research (Print). 1992, Vol 284, Num 4, pp 227-231, issn 0340-3696Article

Pharmacokinetics of therapeutic doses of tropisetron in healthy volunteersKEES, F; FÄRBER, L; BUCHER, M et al.British journal of clinical pharmacology. 2001, Vol 52, Num 6, pp 705-707, issn 0306-5251Article

Cyclosporin new oral formulation for early oral immunosuppressive therapy in liver transplant recipientsWINKLER, M; HALLER, G. W; OLDHAFER, K et al.Transplantation proceedings. 1997, Vol 29, Num 1-2, pp 544-546, issn 0041-1345Conference Paper

Low-dose short-term cyclosporine versus etretinate in psoriasis : improvement of skin, nail, and joint involvementMAHRLE, G; SCHULZE, H.-J; FÄRBER, L et al.Journal of the American Academy of Dermatology. 1995, Vol 32, Num 1, pp 78-88, issn 0190-9622Article

Die Therapie der generalisierten Tendomyopathie (Fibromyalgie) durch Blockierung der 5-HT3-Rezeptoren = Therapy of fibromylgia by blocking of S3-receptorsSTRATZ, T; SCHOCHAT, T; HRYCAJ, P et al.Zeitschrift für Rheumatologie (Print). 1994, Vol 53, Num 6, pp 335-338, issn 0340-1855Article

Cyclosporine in psoriasis : a multicenter dose-finding study in severe plaque psoriasisCHRISTOPHERS, E; MROWIETZ, U; HENNEICKE, H.-H et al.Journal of the American Academy of Dermatology. 1992, Vol 26, Num 1, pp 86-90, issn 0190-9622Article

Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cellsHOHAUS, S; MARTIN, H; WASSMANN, B et al.Bone marrow transplantation (Basingstoke). 1998, Vol 22, Num 7, pp 625-630, issn 0268-3369Article

Downregulation of the proinflammatory cytokine response to endotoxin by pretreatment with the nontoxic lipid A analog SDZ MRL 953 in cancer patientsKIANI, A; TSCHIERSCH, A; MERTELSMANN, R et al.Blood. 1997, Vol 90, Num 4, pp 1673-1683, issn 0006-4971Article